COSMOS PHARMACEUTICAL CORPCOSMOS PHARMACEUTICAL CORPCOSMOS PHARMACEUTICAL CORP

COSMOS PHARMACEUTICAL CORP

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪515.73 B‬JPY
‪24.45 B‬JPY
‪964.99 B‬JPY
‪37.16 M‬
Beta (1Y)
−0.31
Employees (FY)
‪5.51 K‬
Change (1Y)
+222 +4.20%
Revenue / Employee (1Y)
‪175.07 M‬JPY
Net income / Employee (1Y)
‪4.44 M‬JPY

About COSMOS PHARMACEUTICAL CORP


Headquarters
Fukuoka
Founded
1973
ISIN
JP3298400007
FIGI
BBG000Q2PVC7
COSMOS Pharmaceutical Corp. engages in the operation of drugstores. It operates through the following business divisions: Pharmaceutical, Cosmetics, Miscellaneous Goods, General Food, and Others. The Pharmaceutical division markets general drugs, health drinks, oral and nursing care products, vitamins, health food, and dietary food and supplements. The Cosmetics division engages in the sale of skin and hair care products for men and women; and makeup kits. The Miscellaneous Goods division sells detergents, insecticides, toiletries, kitchenware, garden supplies, clothing, and car related products. The General Food division includes processed food, seasonings, bread, pastries, dairy products, beverages, and liquor. The Others division distributes tobacco and cigarettes. The company was founded by Masateru Uno and Noriko Uno in February 1973 and is headquartered in Fukuoka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 3349 is 6,637 JPY — it has increased by 0.26% in the past 24 hours. Watch COSMOS PHARMACEUTICAL CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange COSMOS PHARMACEUTICAL CORP stocks are traded under the ticker 3349.
3349 stock has fallen by −1.14% compared to the previous week, the month change is a −6.55% fall, over the last year COSMOS PHARMACEUTICAL CORP has showed a −18.56% decrease.
We've gathered analysts' opinions on COSMOS PHARMACEUTICAL CORP future price: according to them, 3349 price has a max estimate of 10,000.00 JPY and a min estimate of 6,650.00 JPY. Watch 3349 chart and read a more detailed COSMOS PHARMACEUTICAL CORP stock forecast: see what analysts think of COSMOS PHARMACEUTICAL CORP and suggest that you do with its stocks.
3349 reached its all-time high on Sep 22, 2021 with the price of 10,350 JPY, and its all-time low was 225 JPY and was reached on Oct 10, 2008. View more price dynamics on 3349 chart.
See other stocks reaching their highest and lowest prices.
3349 stock is 2.51% volatile and has beta coefficient of −0.31. Track COSMOS PHARMACEUTICAL CORP stock price on the chart and check out the list of the most volatile stocks — is COSMOS PHARMACEUTICAL CORP there?
Today COSMOS PHARMACEUTICAL CORP has the market capitalization of ‪513.51 B‬, it has decreased by −0.81% over the last week.
Yes, you can track COSMOS PHARMACEUTICAL CORP financials in yearly and quarterly reports right on TradingView.
COSMOS PHARMACEUTICAL CORP is going to release the next earnings report on Jan 10, 2025. Keep track of upcoming events with our Earnings Calendar.
3349 earnings for the last quarter are 102.74 JPY per share, whereas the estimation was 88.57 JPY resulting in a 16.00% surprise. The estimated earnings for the next quarter are 64.02 JPY per share. See more details about COSMOS PHARMACEUTICAL CORP earnings.
COSMOS PHARMACEUTICAL CORP revenue for the last quarter amounts to ‪261.84 B‬ JPY, despite the estimated figure of ‪261.32 B‬ JPY. In the next quarter, revenue is expected to reach ‪246.01 B‬ JPY.
3349 net income for the last quarter is ‪8.14 B‬ JPY, while the quarter before that showed ‪7.10 B‬ JPY of net income which accounts for 14.74% change. Track more COSMOS PHARMACEUTICAL CORP financial stats to get the full picture.
COSMOS PHARMACEUTICAL CORP dividend yield was 0.95% in 2023, and payout ratio reached 19.44%. The year before the numbers were 0.75% and 16.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 27, 2024, the company has ‪5.51 K‬ employees. See our rating of the largest employees — is COSMOS PHARMACEUTICAL CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COSMOS PHARMACEUTICAL CORP EBITDA is ‪54.62 B‬ JPY, and current EBITDA margin is 5.33%. See more stats in COSMOS PHARMACEUTICAL CORP financial statements.
Like other stocks, 3349 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COSMOS PHARMACEUTICAL CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COSMOS PHARMACEUTICAL CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COSMOS PHARMACEUTICAL CORP stock shows the sell signal. See more of COSMOS PHARMACEUTICAL CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.